{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:37:01Z","timestamp":1788953821090,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":954,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41379-019-0449-8","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T09:02:46Z","timestamp":1578301366000},"page":"1078-1091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2\/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2417-3294","authenticated-orcid":false,"given":"Eliah R.","family":"Shamir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0449-8_bib1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","article-title":"Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0449-8_bib2","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","article-title":"Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases","volume":"15","author":"Sneige","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0449-8_bib3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1245\/s10434-011-1563-0","article-title":"The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?","volume":"18","author":"Bagaria","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-019-0449-8_bib4","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","article-title":"Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ","volume":"44","author":"Shin","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-019-0449-8_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.arcmed.2010.08.010","article-title":"Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma","volume":"41","author":"Alvarado-Cabrero","year":"2010","journal-title":"Arch Med Res"},{"key":"10.1038\/s41379-019-0449-8_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","article-title":"Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile","volume":"32","author":"Chivukula","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0449-8_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10549-017-4334-1","article-title":"Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review","volume":"165","author":"De Brot","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-019-0449-8_bib8","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","article-title":"Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-019-0449-8_bib9","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/j.clbc.2017.10.004","article-title":"Pleomorphic lobular carcinoma in situ diagnosed by breast core biopsy: clinicopathologic features and correlation with subsequent excision","volume":"18","author":"Guo","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/s41379-019-0449-8_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/tbj.12843","article-title":"Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast","volume":"24","author":"Fasola","year":"2018","journal-title":"Breast J"},{"key":"10.1038\/s41379-019-0449-8_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","article-title":"Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases","volume":"16","author":"Susnik","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/s41379-019-0449-8_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2010.03634.x","article-title":"Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis","volume":"57","author":"Carder","year":"2010","journal-title":"Histopathology"},{"key":"10.1038\/s41379-019-0449-8_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.breast.2007.04.005","article-title":"Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision","volume":"16","author":"Lavoue","year":"2007","journal-title":"Breast"},{"key":"10.1038\/s41379-019-0449-8_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0000000000001191","article-title":"Pleomorphic and florid lobular carcinoma in situ variants of the breast: a clinicopathologic study of 85 cases with and without invasive carcinoma from a single academic center","volume":"43","author":"Shamir","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0449-8_bib15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/1078-0432.CCR-18-1103","article-title":"Lobular carcinomas in situ display intralesion genetic heterogeneity and clonal evolution in the progression to invasive lobular carcinoma","volume":"25","author":"Lee","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-019-0449-8_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41379-019-0262-4","article-title":"Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ","volume":"32","author":"Harrison","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0449-8_bib17","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.5858\/134.7.e48","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-019-0449-8_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-019-0449-8_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-019-0449-8_bib20","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-019-0449-8_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-019-0449-8_bib22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1038\/s41379-019-0449-8_bib23","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-019-0449-8_bib24","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"10.1038\/s41379-019-0449-8_bib25","doi-asserted-by":"crossref","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinform. 2013;43:11.10.1\u201333.","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"10.1038\/s41379-019-0449-8_bib26","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1038\/s41379-019-0449-8_bib27","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-019-0449-8_bib28","unstructured":"Picard: a set of tools (in Java) for working with next generation sequencing data in the BAM: Broad Institute. http:\/\/broadinstitute.github.io\/picard."},{"key":"10.1038\/s41379-019-0449-8_bib29","unstructured":"Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing. arXiv 2012;1207.3907 [q-bio.GN]."},{"key":"10.1038\/s41379-019-0449-8_bib30","doi-asserted-by":"crossref","first-page":"e26760","DOI":"10.1371\/journal.pone.0026760","article-title":"Differential sensitivity of ERBB2 kinase domain mutations towards lapatinib","volume":"6","author":"Kancha","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1038\/s41379-019-0449-8_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature25475","article-title":"HER kinase inhibition in patients with HER2- and HER3-mutant cancers","volume":"554","author":"Hyman","year":"2018","journal-title":"Nature"},{"key":"10.1038\/s41379-019-0449-8_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/2159-8290.CD-12-0349","article-title":"Activating HER2 mutations in HER2 gene amplification negative breast cancer","volume":"3","author":"Bose","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1038\/s41379-019-0449-8_bib33","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1038\/s41379-019-0449-8_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1038\/s41379-019-0449-8_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ccr.2013.04.012","article-title":"Oncogenic ERBB3 mutations in human cancers","volume":"23","author":"Jaiswal","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-019-0449-8_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-016-0789-y","article-title":"PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression","volume":"19","author":"Shah","year":"2017","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-019-0449-8_bib37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-019-0449-8_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1806","article-title":"Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity","volume":"207","author":"Reis-Filho","year":"2005","journal-title":"J Pathol"},{"key":"10.1038\/s41379-019-0449-8_bib39","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1158\/1078-0432.CCR-07-4960","article-title":"Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study","volume":"14","author":"Iakovlev","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-019-0449-8_bib40","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.18632\/oncotarget.3162","article-title":"Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-019-0449-8_bib41","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1200\/JCO.2015.64.0334","article-title":"Genomic characterization of primary invasive lobular breast cancer","volume":"34","author":"Desmedt","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0449-8_bib42","doi-asserted-by":"crossref","first-page":"73337","DOI":"10.18632\/oncotarget.11819","article-title":"ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas","volume":"7","author":"Deniziaut","year":"2016","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-019-0449-8_bib43","doi-asserted-by":"crossref","unstructured":"Rosa-Rosa JM, Caniego-Casas T, Leskela S, Cristobal E, Gonzalez-Martinez S, Moreno-Moreno E, et al. High frequency of ERBB2 activating mutations in invasive lobular breast carcinoma with pleomorphic features. Cancers (Basel). 2019;11. pii: E74. https:\/\/doi.org\/10.3390\/cancers11010074.","DOI":"10.3390\/cancers11010074"},{"key":"10.1038\/s41379-019-0449-8_bib44","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1158\/1078-0432.CCR-13-0295","article-title":"Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations","volume":"19","author":"Ross","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-019-0449-8_bib45","doi-asserted-by":"crossref","first-page":"80655","DOI":"10.18632\/oncotarget.13019","article-title":"ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast","volume":"7","author":"Ping","year":"2016","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-019-0449-8_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-019-0113-y","article-title":"LobSig is a multigene predictor of outcome in invasive lobular carcinoma","volume":"5","author":"McCart Reed","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"10.1038\/s41379-019-0449-8_bib47","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cncr.30102","article-title":"Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: an emerging opportunity for anti-HER2 targeted therapies","volume":"122","author":"Ross","year":"2016","journal-title":"Cancer"},{"key":"10.1038\/s41379-019-0449-8_bib48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2015.11.001","article-title":"Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: repertoire of somatic genetic alterations and clonal relationships","volume":"10","author":"Sakr","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1038\/s41379-019-0449-8_bib49","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ccr.2013.04.012","article-title":"Oncogenic ERBB3 mutations in human cancers","volume":"23","author":"Jaiswal","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-019-0449-8_bib50","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/annonc\/mdv217","article-title":"Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer","volume":"26","author":"Bidard","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-019-0449-8_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/annonc\/mdv496","article-title":"A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy","volume":"27","author":"Grellety","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-019-0449-8_bib52","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.6004\/jnccn.2015.0131","article-title":"HER2-mutated breast cancer responds to treatment with single-agent neratinib, a second-generation HER2\/EGFR tyrosine kinase inhibitor","volume":"13","author":"Ben-Baruch","year":"2015","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0449-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222008377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222008377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:40:35Z","timestamp":1760229635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222008377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0893395222008377"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0449-8","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2\/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0449-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}